Ranking Invest

TransMedics Group, Inc.

Segmento: Healthcare TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Indicadores Básicos

Valor de Mercado

$ 4.18 Bi

IVR

0.05

IVR2

-0.01

Índices de Previsibilidade

Faturamento

0.42

Lucro

2.64

Margem

1.77

Índices de Tendência

Faturamento

11.59

Lucro

9.01

Margem

9.66

Índices de Endividamento

DIV/PAT

0.78

DIV/L4T

4.25

Dívida Líquida

$ 208.27 Mi

Patrimônio Líquido

$ 266.31 Mi

L4T

$ 48.95 Mi

MM4T

9.52%

Dívidas
Dividendos
Cotação: $122.68

Não há dados de histórico de dividendos para exibir.

Gráfico Lucro/Faturamento X Trimestre